IOVA Iovance Biotherapeutics Inc

Lion Biotechnologies Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases.

$11.47  +0.43 (3.90%)
As of 07/01/2022 15:59:56 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/26/2010
Outstanding shares:  157,168,321
Average volume:  7,206,586
Market cap:   $1,735,138,264
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BF0DMK7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   3.27
PS ratio:   0.00
Return on equity:   -64.93%
Net income %:   0.00%